Benitec Biopharma Stock Plummets After $100M Offering
Update: 2025-11-06
Description
Benitec Biopharmas stock plummets after announcing a $100M stock offering, priced at $13.50 per share, to fund product development and general expenses. The companys unique DNA-directed RNA interference platform, Silence and Replace, remains at the forefront of its genetic medicine creation.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
